We are live on ! Find out more
DMK

DMK Pharmaceuticals Corporation Common Stock
DMK

Delisted

DMK was delisted on the 6th of February, 2024.

Back to rankings

52 hedge funds and large institutions have $14.6M invested in DMK Pharmaceuticals Corporation Common Stock in 2021 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 13 increasing their positions, 9 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

255% more call options, than puts

Call options by funds: $2.53M | Put options by funds: $713K

44% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 9

20% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 5

2% more funds holding

Funds holding: 51 → 52 (+1)

18% less capital invested

Capital invested by funds: $17.8M → $14.6M (-$3.17M)

Holders
52
Holders Change
+1
Holders Change %
+1.96%
% of All Funds
0.91%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
13
Reduced
9
Closed
5
Calls
$2.53M
Puts
$713K
Net Calls
+$1.82M
Net Calls Change
+$894K

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$566K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$513K
3
VF
Virtu Financial
New York
+$214K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$204K
5
Citadel Advisors
Citadel Advisors
Florida
+$71.6K

Top Sellers

Rank Fund Capital Flow
1
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$1.78M
2
GC
Greenlight Capital
New York
-$740K
3
Goldman Sachs
Goldman Sachs
New York
-$266K
4
Squarepoint
Squarepoint
New York
-$106K
5
PCM
Prelude Capital Management
New York
-$72.2K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$6.32M +$204K +2,794 +3%
BlackRock
2
BlackRock
New York
$2.66M +$1.98K +27 +0.1%
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$1.34M +$513K +7,009 +55%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$1.29M +$50K +683 +4%
Millennium Management
5
Millennium Management
New York
$540K +$566K +7,735 +3,453%
State Street
6
State Street
Massachusetts
$408K – – –
GC
7
Greenlight Capital
New York
$283K -$740K -10,109 -71%
Northern Trust
8
Northern Trust
Illinois
$251K – – –
VF
9
Virtu Financial
New York
$199K +$214K +2,927 New
VCA
10
Verdence Capital Advisors
Maryland
$139K – – –
Morgan Stanley
11
Morgan Stanley
New York
$102K +$2.49K +34 +2%
EDRH
12
Edmond de Rothschild Holding
Switzerland
$97K – – –
Citadel Advisors
13
Citadel Advisors
Florida
$88K +$71.6K +978 +307%
Bank of New York Mellon
14
Bank of New York Mellon
New York
$81K – – –
HighTower Advisors
15
HighTower Advisors
Illinois
$66K +$59.4K +812 +467%
Cambridge Investment Research Advisors
16
Cambridge Investment Research Advisors
Iowa
$63K – – –
Charles Schwab
17
Charles Schwab
California
$55K – – –
AI
18
Atom Investors
Texas
$55K +$59.1K +807 New
UBS Group
19
UBS Group
Switzerland
$49K -$10.2K -139 -16%
TRCT
20
Tower Research Capital (TRC)
New York
$49K +$25.2K +344 +90%
Lido Advisors
21
Lido Advisors
California
$45K – – –
RFC
22
Regions Financial Corp
Alabama
$33K – – –
AAS
23
Avantax Advisory Services
Texas
$31K – – –
PCM
24
Prelude Capital Management
New York
$28K -$72.2K -987 -71%
Principal Financial Group
25
Principal Financial Group
Iowa
$27K -$4.76K -65 -14%
1
2 3

DMK Hedge Fund Activity: Q3 2021 in Review

52 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in DMK Pharmaceuticals Corporation Common Stock (DMK) for Q3 2021, worth a combined $14.6M — down 18% from $17.8M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new DMK positions and 5 closed out — a net gain of 1 holder — while 13 added to existing stakes and 9 trimmed.

The largest buyer was Millennium Management, adding an estimated $566K. The largest seller was Balyasny Asset Management, exiting entirely with an estimated $1.78M sold.

  • 52 institutional investors held DMK Pharmaceuticals Corporation Common Stock (DMK) as of Q3 2021, up from 51 in Q2 2021.
  • Funds reported $14.6M of DMK Pharmaceuticals Corporation Common Stock stock for Q3 2021, down 18% quarter-over-quarter.
  • 6 funds opened new DMK Pharmaceuticals Corporation Common Stock positions in Q3 2021 and 5 closed out, a net change of +1 holder.
  • The largest DMK Pharmaceuticals Corporation Common Stock buyer in Q3 2021 was Millennium Management, an estimated $566K added.
  • The largest DMK Pharmaceuticals Corporation Common Stock seller in Q3 2021 was Balyasny Asset Management, an estimated $1.78M sold.

Based on aggregated 13F filings for Q3 2021.